Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Craig A Wheeler. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Craig A Wheeler har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:FOLD / Amicus Therapeutics, Inc. | Director | 84 631 |
US:APLS / Apellis Pharmaceuticals, Inc. | Director | 16 483 |
President & CEO, Director | 0 | |
US:AVNR / Avanir Pharmaceuticals Inc | Director | 400 394 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Craig A Wheeler. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp APLS / Apellis Pharmaceuticals, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i APLS / Apellis Pharmaceuticals, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel APLS / Apellis Pharmaceuticals, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i APLS / Apellis Pharmaceuticals, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internkjøp FOLD / Amicus Therapeutics, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i APLS / Apellis Pharmaceuticals, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel FOLD / Amicus Therapeutics, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i APLS / Apellis Pharmaceuticals, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Craig A Wheeler som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 20 414 | 84 631 | 31,79 | ||||
2025-04-21 |
|
4 | APLS |
Apellis Pharmaceuticals, Inc.
Common Stock |
A - Award | 16 483 | 16 483 | |||||
2024-06-07 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 11 847 | 64 217 | 22,62 | ||||
2023-06-12 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 8 584 | 52 370 | 19,60 | ||||
2022-06-10 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 12 671 | 43 786 | 40,72 | ||||
2021-06-14 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
A - Award | 36 111 | 36 111 | |||||
2021-06-14 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 10 115 | 31 115 | 48,17 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −196 863 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −483 163 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −191 366 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −169 085 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −118 125 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 875 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −132 319 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 681 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −134 433 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −142 051 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 949 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −142 415 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 585 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −3 137 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 837 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 134 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −15 915 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −5 567 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −250 500 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −100 000 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −37 032 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −11 563 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −389 120 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −48 263 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −36 725 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −8 739 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
G - Gift | −190 476 | 389 120 | −32,86 | ||||
2020-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 777 | 15 313 | −15,35 | 28,55 | −79 283 | 437 186 |
2020-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 171 | 37 032 | −14,28 | ||||
2020-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 171 | 18 090 | 51,77 | ||||
2020-08-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 11 919 | −17,91 | 31,21 | −81 177 | 371 992 |
2020-08-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 11 563 | −33,33 | ||||
2020-08-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 14 520 | 66,15 | ||||
2020-07-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −37 575 | 54 664 | −40,74 | 33,32 | −1 251 999 | 1 821 404 |
2020-07-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 83 500 | 250 500 | 50,00 | ||||
2020-07-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 83 500 | 92 239 | 955,49 | ||||
2020-06-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −37 575 | 54 664 | −40,74 | 30,56 | −1 148 292 | 1 670 532 |
2020-06-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 83 500 | 167 000 | 100,00 | ||||
2020-06-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 83 500 | 92 239 | 955,49 | ||||
2020-06-08 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
A - Award | 18 574 | 18 574 | |||||
2020-06-08 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 5 855 | 21 000 | 38,66 | ||||
2020-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 778 | 15 313 | −15,36 | 31,23 | −86 757 | 478 225 |
2020-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 172 | 43 203 | −12,50 | ||||
2020-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 172 | 18 091 | 51,78 | ||||
2020-05-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 602 | 11 919 | −17,92 | 32,94 | −85 710 | 392 612 |
2020-05-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 782 | 17 344 | −25,00 | ||||
2020-05-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 782 | 14 521 | 66,16 | ||||
2020-03-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −347 | 54 664 | −0,63 | 28,75 | −9 976 | 1 571 590 |
2020-03-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −37 228 | 55 011 | −40,36 | 28,51 | −1 061 370 | 1 568 364 |
2020-03-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 83 500 | 83 500 | |||||
2020-03-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 83 500 | 92 239 | 955,49 | ||||
2020-02-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | 21 894 | 0 | −100,00 | |||
2020-02-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −21 894 | 17 478 | −55,61 | 32,00 | −700 608 | 559 296 |
2020-02-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 21 894 | 39 372 | 125,27 | 13,26 | 290 314 | 522 073 |
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 778 | 17 478 | −13,71 | 30,82 | −85 618 | 538 672 |
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 4 581 | 21 894 | 26,46 | ||||
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restriced Stock Units |
A - Award | 6 172 | 49 375 | 14,29 | ||||
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 172 | 20 256 | 43,82 | ||||
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 581 | 14 084 | −24,54 | 32,01 | −146 638 | 450 829 |
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 581 | 18 665 | 32,53 | 13,26 | 60 744 | 247 498 |
2020-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −31 178 | 26 475 | −54,08 | |||
2020-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −4 124 | 0 | −100,00 | |||
2020-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 773 | 14 084 | −11,18 | 31,89 | −56 541 | 449 139 |
2020-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −35 302 | 15 857 | −69,00 | 32,10 | −1 133 194 | 509 010 |
2020-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 35 302 | 51 159 | 222,63 | 13,26 | 468 105 | 678 368 |
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 15 857 | −14,09 | 31,43 | −81 749 | 498 386 |
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 23 126 | −20,00 | ||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 467 | 57 653 | −4,10 | |||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 423 | 4 124 | −37,01 | |||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 200 000 | 200 000 | |||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restriced Stock Units |
A - Award | 100 000 | 100 000 | |||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 18 458 | 45,60 | ||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 890 | 12 677 | −27,84 | 32,04 | −156 676 | 406 171 |
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 890 | 17 567 | 38,57 | 13,26 | 64 841 | 232 938 |
2020-02-07 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −12 229 | 60 120 | −16,90 | |||
2020-02-07 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 229 | 12 677 | −49,10 | 30,21 | −369 438 | 382 972 |
2020-02-07 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 229 | 24 906 | 96,47 | 13,26 | 162 157 | 330 254 |
2020-02-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −15 505 | 72 349 | −17,65 | |||
2020-02-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 505 | 12 677 | −55,02 | 30,04 | −465 770 | 380 817 |
2020-02-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 505 | 28 182 | 122,31 | 13,26 | 205 596 | 373 693 |
2020-02-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −5 599 | 87 854 | −5,99 | |||
2020-02-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 599 | 12 677 | −30,64 | 30,02 | −168 082 | 380 564 |
2020-02-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 599 | 18 276 | 44,17 | 13,26 | 74 243 | 242 340 |
2019-12-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 514 | 0 | −100,00 | |||
2019-12-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −24 820 | 0 | −100,00 | |||
2019-12-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −33 334 | 12 677 | −72,45 | 16,69 | −556 344 | 211 579 |
2019-12-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 33 334 | 46 011 | 262,95 | 15,37 | 512 344 | 707 189 |
2019-11-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −66 666 | 24 820 | −72,87 | |||
2019-11-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −66 666 | 12 677 | −84,02 | 17,00 | −1 133 322 | 215 509 |
2019-11-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 66 666 | 79 343 | 525,88 | 15,37 | 1 024 656 | 1 219 502 |
2019-11-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 778 | 12 677 | −17,97 | 16,25 | −45 142 | 206 001 |
2019-11-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 172 | 55 547 | −10,00 | ||||
2019-11-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 172 | 15 455 | 66,49 | ||||
2019-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 772 | 9 283 | −16,03 | 16,49 | −29 220 | 153 077 |
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 11 055 | −19,05 | 16,16 | −42 032 | 178 649 |
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 28 907 | −16,67 | ||||
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 13 656 | 73,41 | ||||
2019-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 778 | 16 614 | −14,33 | 11,93 | −33 142 | 198 205 |
2019-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 172 | 61 719 | −9,09 | ||||
2019-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 172 | 19 392 | 46,69 | ||||
2019-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 773 | 13 220 | −11,83 | 11,74 | −20 815 | 155 203 |
2019-08-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 14 993 | −14,78 | 11,72 | −30 484 | 175 718 |
2019-08-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 34 688 | −14,29 | ||||
2019-08-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 17 594 | 48,94 | ||||
2019-07-01 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
A - Award | 19 473 | 19 473 | |||||
2019-07-01 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 6 250 | 15 145 | 70,26 | ||||
2019-05-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 778 | 20 552 | −11,91 | 13,72 | −38 114 | 281 973 |
2019-05-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 172 | 67 891 | −8,33 | ||||
2019-05-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 172 | 23 330 | 35,97 | ||||
2019-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 772 | 17 158 | −9,36 | 14,13 | −25 038 | 242 443 |
2019-05-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 18 930 | −12,08 | 13,98 | −36 362 | 264 641 |
2019-05-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 40 469 | −12,50 | ||||
2019-05-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 21 531 | 36,70 | ||||
2019-04-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −75 000 | 15 750 | −82,64 | ||||
2019-02-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 435 | 177 067 | −0,80 | 14,08 | −20 205 | 2 493 103 |
2019-02-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −16 875 | 178 502 | −8,64 | 12,67 | −213 806 | 2 261 620 |
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 110 | 195 377 | −5,38 | 12,93 | −143 652 | 2 526 225 |
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −24 687 | 74 063 | −25,00 | ||||
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 24 687 | 206 487 | 13,58 | ||||
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 773 | 181 800 | −0,97 | 12,84 | −22 765 | 2 334 312 |
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 491 000 | 491 000 | |||||
2019-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 183 573 | −1,40 | 11,76 | −30 588 | 2 158 818 |
2019-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 46 250 | −11,11 | ||||
2019-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 186 174 | 3,20 | ||||
2018-11-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 180 393 | −1,08 | 12,38 | −24 376 | 2 233 265 |
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 772 | 182 362 | −0,96 | 12,63 | −22 380 | 2 303 232 |
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 782 | 52 031 | −10,00 | ||||
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 602 | 184 134 | −1,39 | 14,09 | −36 662 | 2 594 448 |
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 782 | 186 736 | 3,20 | ||||
2018-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 183 360 | −1,06 | 27,43 | −54 010 | 5 029 565 |
2018-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 773 | 190 674 | −0,92 | 26,06 | −46 204 | 4 968 964 |
2018-08-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 57 813 | −9,09 | ||||
2018-08-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 192 447 | −1,33 | 28,74 | −74 753 | 5 530 927 |
2018-08-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 195 048 | 3,05 | ||||
2018-06-11 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Option (right to buy) |
A - Award | 8 912 | 8 912 | |||||
2018-06-11 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
A - Award | 3 081 | 8 895 | 52,99 | ||||
2018-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 191 673 | −1,02 | 23,33 | −45 937 | 4 471 731 |
2018-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 772 | 198 987 | −0,88 | 21,86 | −38 736 | 4 349 856 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 63 594 | −8,33 | ||||
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 200 759 | −1,28 | 20,21 | −52 566 | 4 057 339 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 203 360 | 2,93 | ||||
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −33 333 | 0 | −100,00 | |||
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 339 645 | −2,86 | 21,00 | −210 000 | 7 132 545 |
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −33 333 | 197 579 | −14,44 | 21,00 | −699 993 | 4 149 159 |
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 33 333 | 230 912 | 16,87 | 10,43 | 347 663 | 2 408 412 |
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −32 433 | 33 333 | −49,32 | |||
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 004 | 349 645 | −1,41 | 20,75 | −103 833 | 7 255 134 |
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −32 433 | 197 579 | −14,10 | 20,68 | −670 714 | 4 085 934 |
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 32 433 | 230 012 | 16,42 | 10,43 | 338 276 | 2 399 025 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −900 | 65 766 | −1,35 | |||
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 996 | 354 649 | −1,39 | 21,00 | −104 916 | 7 447 629 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −900 | 197 579 | −0,45 | 21,00 | −18 900 | 4 149 159 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 900 | 198 479 | 0,46 | 10,43 | 9 387 | 2 070 136 |
2018-04-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −33 334 | 55 269 | −37,62 | |||
2018-04-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 359 645 | −2,71 | 19,00 | −190 000 | 6 833 255 |
2018-04-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −33 334 | 197 579 | −14,44 | 19,00 | −633 346 | 3 754 001 |
2018-04-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 33 334 | 230 913 | 16,87 | 10,43 | 347 674 | 2 408 423 |
2018-02-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 237 900 | −0,82 | 16,45 | −32 390 | 3 913 455 |
2018-02-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 239 869 | −0,81 | 16,46 | −32 410 | 3 948 244 |
2018-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −16 875 | 241 838 | −6,52 | 16,14 | −272 362 | 3 903 265 |
2018-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 197 500 | 197 500 | |||||
2018-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 98 750 | 98 750 | |||||
2018-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 773 | 258 713 | −0,68 | 16,18 | −28 687 | 4 185 976 |
2018-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | 23 125 | 69 375 | 50,00 | ||||
2018-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 406 | 260 486 | −3,84 | 15,89 | −165 351 | 4 139 123 |
2018-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 23 125 | 275 526 | 9,16 | ||||
2018-01-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −25 666 | 0 | −100,00 | |||
2018-01-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 324 690 | −2,99 | 14,10 | −141 000 | 4 578 129 |
2018-01-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −25 666 | 252 401 | −9,23 | 14,11 | −362 147 | 3 561 378 |
2018-01-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 25 666 | 278 067 | 10,17 | 7,41 | 190 185 | 2 060 476 |
2017-11-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 252 401 | −0,81 | 13,35 | −27 474 | 3 369 553 |
2017-11-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 254 459 | −0,80 | 13,34 | −27 454 | 3 394 483 |
2017-11-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 852 | 258 602 | −0,71 | 13,25 | −24 539 | 3 426 476 |
2017-10-02 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −25 667 | 25 666 | −50,00 | |||
2017-10-02 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 282 638 | −3,42 | 19,02 | −190 200 | 5 375 775 |
2017-10-02 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −25 667 | 260 454 | −8,97 | 19,03 | −488 443 | 4 956 440 |
2017-10-02 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 25 667 | 286 121 | 9,85 | 7,41 | 190 192 | 2 120 157 |
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −14 167 | 51 333 | −21,63 | |||
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −450 | 292 638 | −0,15 | 17,00 | −7 650 | 4 974 846 |
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −14 167 | 260 454 | −5,16 | 17,00 | −240 839 | 4 427 718 |
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 14 167 | 274 621 | 5,44 | 7,41 | 104 977 | 2 034 942 |
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 300 | 65 500 | −3,39 | |||
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 450 | 293 088 | −1,16 | 17,00 | −58 650 | 4 982 496 |
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 300 | 260 454 | −0,88 | 17,00 | −39 100 | 4 427 718 |
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 300 | 262 754 | 0,88 | 7,41 | 17 043 | 1 947 007 |
2017-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 267 173 | −0,76 | 15,07 | −31 014 | 4 026 297 |
2017-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 269 231 | −0,76 | 15,06 | −30 993 | 4 054 619 |
2017-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −9 100 | 67 800 | −11,83 | |||
2017-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 289 819 | −2,03 | 17,00 | −102 000 | 4 926 923 |
2017-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 853 | 271 289 | −0,68 | 16,47 | −30 519 | 4 468 130 |
2017-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 100 | 273 142 | −3,22 | 17,00 | −154 700 | 4 643 414 |
2017-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 100 | 282 242 | 3,33 | 7,41 | 67 431 | 2 091 413 |
2017-08-04 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −100 | 76 900 | −0,13 | |||
2017-08-04 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 289 100 | −0,03 | 17,00 | −1 700 | 4 914 700 |
2017-08-04 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 289 100 | −0,03 | 17,00 | −1 700 | 4 914 700 |
2017-08-04 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 100 | 279 961 | 0,04 | 7,41 | 741 | 2 074 511 |
2017-06-15 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Option (right to buy) |
A - Award | 16 236 | 16 236 | |||||
2017-06-15 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
A - Award | 5 814 | 5 814 | |||||
2017-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 279 861 | −0,73 | 15,83 | −32 578 | 4 430 200 |
2017-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 279 861 | −0,73 | 15,83 | −32 578 | 4 430 200 |
2017-05-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 852 | 283 977 | −0,65 | 15,77 | −29 206 | 4 478 317 |
2017-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 301 365 | −0,65 | 15,51 | −30 539 | 4 674 171 |
2017-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 301 365 | −0,65 | 15,51 | −30 539 | 4 674 171 |
2017-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 305 303 | −0,55 | 15,51 | −26 181 | 4 735 250 |
2017-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 088 | 306 991 | −2,26 | 18,85 | −133 609 | 5 786 780 |
2017-02-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 92 500 | 92 500 | |||||
2017-02-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 185 000 | 185 000 | |||||
2016-11-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 764 | 320 699 | −0,55 | 14,05 | −24 784 | 4 505 821 |
2016-11-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 322 463 | −0,63 | 13,52 | −27 824 | 4 359 700 |
2016-11-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 058 | 748 445 | −0,27 | 13,52 | −27 824 | 10 118 976 | |
2016-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 764 | 333 199 | −0,53 | 12,00 | −21 168 | 3 998 388 |
2016-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 334 963 | −0,61 | 12,04 | −24 778 | 4 032 955 |
2016-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 337 021 | −0,61 | 12,03 | −24 758 | 4 054 363 |
2016-06-13 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Option (right to buy) |
A - Award | 30 000 | 30 000 | |||||
2016-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 764 | 345 699 | −0,51 | 10,13 | −17 869 | 3 501 931 |
2016-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 347 463 | −0,59 | 10,20 | −20 992 | 3 544 123 |
2016-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 347 463 | −0,59 | 10,20 | −20 992 | 3 544 123 |
2016-04-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
F - Taxes | −26 608 | 351 579 | −7,04 | 9,69 | −257 832 | 3 406 801 | |
2016-04-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 150 000 | 378 187 | 65,74 | ||||
2016-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 244 342 | −0,69 | 9,95 | −16 796 | 2 431 203 |
2016-02-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 875 | 246 030 | −3,10 | 9,37 | −73 789 | 2 305 301 |
2016-02-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 253 905 | −0,77 | 9,35 | −18 410 | 2 374 012 |
2016-02-18 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 255 874 | −0,66 | 11,30 | −19 074 | 2 891 376 |
2016-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 126 000 | 126 000 | |||||
2016-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 63 000 | 257 562 | 32,38 | ||||
2015-11-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 766 | 200 844 | −0,87 | 17,86 | −31 541 | 3 587 074 |
2015-11-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 061 | 202 610 | −1,01 | 18,05 | −37 201 | 3 657 110 |
2015-11-18 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 766 | 204 671 | −0,86 | 17,70 | −31 258 | 3 622 677 |
2015-11-06 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | 41 667 | 83 333 | 100,00 | |||
2015-11-06 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 177 314 | −5,34 | 18,00 | −180 000 | 3 191 652 |
2015-11-06 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −41 667 | 206 437 | −16,79 | 18,00 | −750 006 | 3 715 866 |
2015-11-06 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 41 667 | 248 104 | 20,18 | 16,18 | 674 172 | 4 014 323 |
2015-08-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 766 | 212 719 | −0,82 | 22,28 | −39 346 | 4 739 379 |
2015-08-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 061 | 214 485 | −0,95 | 22,02 | −45 383 | 4 722 960 |
2015-08-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 766 | 216 546 | −0,81 | 21,77 | −38 446 | 4 714 206 |
2015-06-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −125 000 | 125 000 | −50,00 | |||
2015-06-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 181 032 | −14,22 | 24,11 | −723 300 | 4 364 682 |
2015-06-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −125 000 | 218 312 | −36,41 | 24,22 | −3 027 500 | 5 287 517 |
2015-06-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 125 000 | 343 312 | 57,26 | 16,18 | 2 022 500 | 5 554 788 |
2015-06-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −83 333 | 250 000 | −25,00 | |||
2015-06-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 211 032 | −8,66 | 22,00 | −440 000 | 4 642 704 |
2015-06-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −83 333 | 218 312 | −27,63 | 22,00 | −1 833 326 | 4 802 864 |
2015-06-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 83 333 | 301 645 | 38,17 | 16,18 | 1 348 328 | 4 880 616 |
2015-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 766 | 224 594 | −0,78 | 19,68 | −34 755 | 4 420 010 |
2015-05-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 061 | 226 360 | −0,90 | 19,67 | −40 540 | 4 452 501 |
2015-05-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 766 | 228 421 | −0,77 | 19,92 | −35 179 | 4 550 146 |
2015-04-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | 41 667 | 333 333 | 14,29 | |||
2015-04-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 196 308 | −4,85 | 20,00 | −200 000 | 3 926 160 |
2015-04-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −41 667 | 258 629 | −13,88 | 20,00 | −833 340 | 5 172 580 |
2015-04-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 41 667 | 300 296 | 16,11 | 16,18 | 674 172 | 4 858 789 |
2015-04-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 269 | 258 629 | −2,37 | 18,75 | −117 544 | 4 849 294 |
2015-04-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common tock |
F - Taxes | −27 977 | 264 898 | −9,55 | 17,08 | −477 847 | 4 524 458 | |
2015-04-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −22 125 | 292 875 | −7,02 | ||||
2015-02-25 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 110 | 337 769 | −0,62 | 13,52 | −28 527 | 4 566 637 |
2015-02-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 339 879 | −0,49 | 13,37 | −22 569 | 4 544 182 |
2015-02-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 875 | 341 567 | −2,25 | 13,52 | −106 470 | 4 617 986 |
2015-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 140 000 | 1 332 000 | 11,74 | 13,02 | 1 822 800 | 17 342 640 | |
2015-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 349 442 | −0,48 | 11,91 | −20 104 | 4 161 854 |
2015-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 70 000 | 351 130 | 24,90 | ||||
2014-11-26 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 210 | 281 130 | −0,78 | 11,59 | −25 614 | 3 258 297 |
2014-11-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 768 | 364 773 | −0,48 | 11,10 | −19 625 | 4 048 980 |
2014-11-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 768 | 366 541 | −0,48 | 10,58 | −18 705 | 3 878 004 |
2014-08-26 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 209 | 368 309 | −0,60 | 11,45 | −25 293 | 4 217 138 |
2014-08-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 768 | 370 518 | −0,47 | 11,54 | −20 403 | 4 275 778 |
2014-08-18 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 768 | 372 286 | −0,47 | 11,75 | −20 774 | 4 374 360 |
2014-05-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 110 | 374 054 | −0,56 | 12,06 | −25 447 | 4 511 091 |
2014-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 376 164 | −0,45 | 12,08 | −20 391 | 4 544 061 |
2014-05-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 687 | 377 852 | −0,44 | 11,09 | −18 709 | 4 190 379 |
2014-02-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 379 539 | −0,55 | 17,47 | −36 844 | 6 630 546 |
2014-02-25 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 750 | 381 648 | −1,74 | 17,68 | −119 340 | 6 747 537 |
2014-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 110 | 388 398 | −0,54 | 17,86 | −37 685 | 6 936 788 |
2014-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Righ to Buy) |
A - Award | 140 000 | 1 192 000 | 13,31 | ||||
2014-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 70 000 | 390 508 | 21,84 | ||||
2014-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 687 | 320 508 | −0,52 | 17,96 | −30 299 | 5 756 324 |
2014-02-14 |
|
4 | AVNR |
AVANIR PHARMACEUTICALS, INC.
Common Stock |
A - Award | 28 900 | 400 394 | 7,78 | ||||
2013-11-26 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 215 | 322 195 | −0,68 | 17,77 | −39 361 | 5 725 405 |
2013-11-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 215 | 324 410 | −0,68 | 17,17 | −38 032 | 5 570 120 |
2013-11-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 772 | 326 625 | −0,54 | 16,88 | −29 911 | 5 513 430 |
2013-08-26 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 328 397 | −0,64 | 14,90 | −31 424 | 4 893 115 |
2013-08-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 330 506 | −0,63 | 14,47 | −30 517 | 4 782 422 |
2013-08-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 332 615 | −0,50 | 15,43 | −26 046 | 5 132 249 |
2013-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 334 303 | −0,63 | 13,03 | −27 480 | 4 355 968 |
2013-05-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 336 412 | −0,62 | 12,83 | −27 058 | 4 316 166 |
2013-05-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 687 | 338 521 | −0,50 | 13,33 | −22 488 | 4 512 485 |
2013-02-26 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 340 208 | −0,62 | 12,58 | −26 531 | 4 279 817 |
2013-02-26 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 342 317 | −0,61 | 12,43 | −26 215 | 4 255 000 |
2013-02-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 344 426 | −0,61 | 12,62 | −26 616 | 4 346 656 |
2013-02-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 150 000 | 1 052 000 | 16,63 | ||||
2013-02-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 60 000 | 346 535 | 20,94 | ||||
2013-02-19 |
|
4 | AVNR |
AVANIR PHARMACEUTICALS, INC.
Common Stock |
A - Award | 38 900 | 371 494 | 11,70 | ||||
2013-02-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 750 | 286 535 | −2,30 | 12,16 | −82 080 | 3 484 266 |
2012-11-28 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 293 285 | −0,71 | 10,53 | −22 208 | 3 088 291 |
2012-11-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 295 394 | −0,71 | 10,58 | −22 313 | 3 125 269 |
2012-11-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 297 503 | −0,70 | 10,96 | −23 115 | 3 260 633 |
2012-08-30 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 299 612 | −0,70 | 14,21 | −29 969 | 4 257 487 |
2012-08-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 301 721 | −0,69 | 13,57 | −28 619 | 4 094 354 |
2012-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 303 830 | −0,69 | 13,63 | −28 746 | 4 141 203 |
2012-05-31 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 110 | 331 719 | −0,63 | 13,79 | −29 097 | 4 574 405 |
2012-05-25 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 333 829 | −0,63 | 13,98 | −29 484 | 4 666 929 |
2012-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 110 | 335 938 | −0,62 | 14,15 | −29 856 | 4 753 523 |
2012-03-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 322 580 | −0,65 | 15,00 | −31 635 | 4 838 700 |
2012-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 438 | 324 689 | −2,53 | 15,45 | −130 367 | 5 016 445 |
2012-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 110 | 333 127 | −0,63 | 15,45 | −32 600 | 5 146 812 |
2012-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 335 237 | −0,63 | 15,07 | −31 783 | 5 052 022 |
2012-02-17 |
|
4 | AVNR |
AVANIR PHARMACEUTICALS, INC.
Common Stock |
A - Award | 30 000 | 327 594 | 10,08 | ||||
2012-02-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 150 000 | 902 000 | 19,95 | ||||
2012-02-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 60 000 | 337 346 | 21,63 | ||||
2007-03-05 |
|
4 | AVNR |
AVANIR PHARMACEUTICALS
Class A Common Stock |
A - Award | 11 752 | 50 683 | 30,19 | ||||
2007-03-05 |
|
4 | AVNR |
AVANIR PHARMACEUTICALS
Class A Common Stock |
A - Award | 32 496 | 38 931 | 504,99 | ||||
2006-02-15 |
|
4 | AVN |
AVANIR PHARMACEUTICALS
Class A Common Stock |
A - Award | 6 435 | 6 435 |